AuXin Surgery was incorporated in Belgium in January 2014 as a limited liability company. The Company is the pioneer of devices for chemically assisted dissection (CADISS® Method) in surgery. The objective is to make available to surgeons this novel method for use in many surgical procedures. The Company develops and sells complete CADISS® systems for targeted applications..
AuXin Surgery is ISO 13485 (2016) certified.
CHIEF SCIENTIFIC OFFICER
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 882323.